Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Pharmaceuticals Company Reports

1594

Research your competitors and discover new corporate prospects in the pharmaceutical industry with company reports and profiles.

RSS Feeds

All reports in Pharmaceuticals Company Reports

< prev 1  2  3  4  5  6  7  8  9  10  next >
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
5/21/2012 | published by: GlobalData
... and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on partnerships, licensing agreements, M&As, equity/debt offerings, private equity and venture financing ...  |  more...
$1,500.00
Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... company develops, manufactures and sells nutraceutical and pharmaceutical products. It offers three product lines, namely, Appeton, Axcel and Vaxcel. Its product portfolio includes over-the-counter (OTC) health supplements and prescriptive products. Kotra offers dosage forms, such ...  |  more...
$250.00
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... focus is on the development of Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which it is developing to improve the tolerability and effectiveness of 5-fluorouracil (5-FU). Eniluracil is in Phase II trial for metastatic breast ...  |  more...
$125.00
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... Bayer Group, the company’s business operations are classified into three subgroups, namely Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The company offers around 5,000 products which include pharmaceuticals for both human and animal health markets, ...  |  more...
$125.00
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... The company operates through four reportable business segments, namely, Xepa, Apex Pharma, International and Corporate. The company also provides property rental and management; and the licensing of Apex Pharmacy trademark services. Apex distributes various brands ...  |  more...
$250.00
Aanjaneya Lifecare Limited (AANJANEYA) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), including anti malarial, expectorant, ace inhibitor, animal health products, anti cancer, analgesics, lozenges, topicals, anti obesity, anti TB, herbal products, multi-vitamins, and others. Aanjaneya’s key therapeutic areas ...  |  more...
$125.00
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... coagulant products, industrial and specialty chemicals, and pharmaceutical and healthcare products. The company also provides designing, installing, commissioning and manufacturing and maintenance services for the purification of water and waste water treatment plant systems. The ...  |  more...
$125.00
Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... The company operates in two business segments, namely, Pharmaceutical segment, which carries out manufacturing and selling pharmaceutical products; and Phytonutrient segment, which involves in the extraction and processing of nutrients used in producing pharmaceutical phytonutrients, ...  |  more...
$250.00
Cytokinetics, Incorporated (CYTK) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... modulation of muscle function for various diseases and medical conditions. The company focuses its research and development programs related to the biology of muscle function modulating the contractility of cardiac, skeletal and smooth muscle. The ...  |  more...
$125.00
Columbia Laboratories Inc. (CBRX) - Financial and Strategic SWOT Analysis Review
5/16/2012 | published by: GlobalData
... its proprietary bioadhesive delivery system (BDS) technology. The company’s product portfolio comprises of five marketed and one pipeline drug. The company’s marketed products can be divided into Men’s health and Women’s health. The Women’s health ...  |  more...
$125.00
Agenus, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Agenus, Inc.’s corporate website, ...  |  more...
$500.00
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ADVENTRX Pharmaceuticals’s corporate ...  |  more...
$500.00
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...  |  more...
$500.00
Eli Lilly and Company – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s ...  |  more...
$500.00
Emergent BioSolutions Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Emergent ...  |  more...
$500.00
Evotec Aktiengesellschaft – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Evotec Aktiengesellschaft’s corporate website, ...  |  more...
$500.00
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Neuren ...  |  more...
$500.00
Newron Pharmaceuticals S.p.A. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Newron ...  |  more...
$500.00
Vertex Pharmaceuticals Incorporated – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Vertex ...  |  more...
$500.00
Sigma-Tau S.p.A. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sigma-Tau S.p.A.’s corporate website, ...  |  more...
$500.00
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s ...  |  more...
$500.00
Wilex AG – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Wilex AG’s corporate website, ...  |  more...
$500.00
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Ferring ...  |  more...
$500.00
Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Spectrum ...  |  more...
$500.00
Keryx Biopharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
... The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Keryx ...  |  more...
$500.00
< prev 1  2  3  4  5  6  7  8  9  10  next >